Regulatory

'Pathways Picks' August 7: The News this Week

'Pathways Picks' August 7: The News this Week

Welcome to the August 7 edition of ‘Pathways’ Picks,’ our MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: CMS has been busy in the past week rolling out policy proposals. We spotlight a few key takeaways for medtech. And more to watch from China, the US, and Germany.

'Pathways Picks' July 24: The News this Week

'Pathways Picks' July 24: The News this Week

Welcome to the July 24 edition of ‘Pathways Picks’, MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: a gathering on device interoperability, a global focus on cybersecurity and software oversight, assessing tech assessment, and more. Download a copy of the first issue of Market Pathways and look for updates here.

'Pathways Picks' July 10: The News this Week

'Pathways Picks' July 10: The News this Week

Welcome to the July 10 edition of ‘Pathways Picks’, our MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: Elizabeth Warren watches the device space, China pilots UDI, another notified body bows out and more. Download a copy of the first issue of Market Pathways and look for updates here.

MedTech Strategist Market Pathways: A Press Release

MedTech Strategist Market Pathways: A Press Release

This week MedTech Strategist is launching a new publication to deliver global regulatory and reimbursement insights to the medical device industry: MedTech Strategist Market Pathways: Global Regulatory, Reimbursement, and Policy Review. The highly-anticipated publication will be the go-to source to help industry make sense of the increasingly complex web of medtech market access policies worldwide.

Expert Perspective: The Community Blog Checks In with Jeffrey Shuren

Expert Perspective: The Community Blog Checks In with Jeffrey Shuren

At the recent MedTech Conference powered by AdvaMed, held in Philadelphia, the Community Blog caught up with Jeffrey Shuren, MD, JD, Director, Center for Devices and Radiological Health (CDRH) at the FDA. We asked him what he thought about today’s medical device regulatory climate, and where he sees the industry overall headed in the next few years. Hint: Shuren’s optimistic vision for the future of the CDRH embodies the overall theme of everything we do here at the Community Blog - build a community. Our Q&A is included below.